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Abstract
Background: Diabetic retinopathy is the most common ocular complication of diabetes and a cause of vision loss
in adults. Diabetic retinopathy screening leading to early identification of the disease followed by timely treatment,
can prevent vision loss in people living with diabetes. A key barrier to the implementation of screening services in
low- and middle-income countries is the low number of ophthalmologists per million population. Interventions that
shift screening to non-ophthalmology cadres have been implemented in programmes in low- and middle-income
countries and are routinely used in high-income countries. The aim of this rapid review is to summarise the
published literature reporting the effectiveness of task-shifting interventions for the detection of diabetic
retinopathy by non-ophthalmologists in low- and middle-income countries.
Methods: We will search MEDLINE, Embase, Global Health and Cochrane Register of Studies for studies
reporting task-shifting interventions for diabetic retinopathy detection. The review will include studies
published in the last 10 years in the English language. We will include any interventional or observational
comparative study measuring outcomes in terms of participation or access to diabetic retinopathy detection
services (uptake) and quality of diabetic retinopathy detection services (detection, severity, diagnostic
accuracy). For included studies, cost-effectiveness of the task-shifting intervention will also be presented. Two
reviewers will screen search results independently. The risk of bias assessment and data extraction will be
carried out by one reviewer with verification of 10% of the papers by a second reviewer. The results will be
synthesised narratively.
Discussion: Differences in health systems organization, structure and resources will determine the need and
success of task-shifting interventions for DR screening. The review will examine how these interventions have
been used and/or tested in LMICs. The results will be of interest to policy makers and programme managers
tasked with designing and implementing services to prevent and manage diabetes and its complications in
similar settings.
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Background
Diabetic retinopathy (DR) is the most frequent micro-
vascular complication of diabetes and a significant cause
of vision loss in adults [1]. Vision loss due to DR can
largely be prevented through regular retinal screening
for timely identification of DR, followed by referral and
treatment [2–5].
DR screening has been shown to be cost-effective
when compared to no screening or opportunistic screen-
ing [3, 6, 7]. However, cost-effectiveness requires high
coverage and this is challenging in low- and middle-
income (LMICs) countries [8] where the available eye
health services are clustered around the cities and access
to them from the remote and rural populations is often
difficult [9]. Few countries worldwide have been success-
ful in establishing population-based screening pro-
grammes that reach most of the patients with diabetes
[3]. The uptake of retinal screening depends on context-
specific factors related to the service provider, the wider
organization and structure of the health system and the
patient [10–12].
A crucial limitation to deliver DR screening in LMICs
is the low availability of ophthalmologists, particularly in
sub-Saharan Africa (SSA), where the mean ophthalmolo-
gist density per million population is 3.7 [13]. In this
context, it is not realistic to rely on ophthalmologists to
examine the retinas of the growing population of people
living with diabetes (PLWD) unless it is at the expense
of the delivery of other critical eye care services. This is
not only a challenge for LMICs, and programmes in
high-income countries (HICs) have overcome this issue
by successfully adopting task-shifting in DR screening by
training retinal graders, thus freeing ophthalmologists
time to perform other tasks [14]. The WHO defines
task-shifting as the transfer of tasks to existing cadres of
healthcare workers with shorter training and fewer qual-
ifications or to newly created cadres who receive a
competency-based training for the specific task [15].
There is some evidence of the successful use of task-
shifting in SSA in other health fields including diabetes
[16, 17]. However, it is not clear whether task-shifting
interventions for the detection of DR in LMICs results
in an increase in the uptake of screening and higher DR
detection rate.
There are several factors that can potentially affect the
effectiveness of task-shifting interventions for DR
screening. Firstly, the choice, level and training of the
cadre performing the screening is a key consideration
and is likely to be different depending on the compos-
ition and competencies of the health workforce in a par-
ticular country. The quality of the screening is measured
by the diagnostic test accuracy (DTA) of the method of
choice in the hands of non-ophthalmologists [18]. It is
recommended that population-based screening pro-
grammes should reach over 80% sensitivity and 95% spe-
cificity [6, 19]. Screening performed by photographers
has been shown to be more accurate when done by pho-
tographers with specialist medical or eye care qualifica-
tions [20]. There is also evidence that non-medical
retinal image graders can achieve the threshold level of
sensitivity and specificity in both mydriatic and non-
mydriatic retinal assessment [18].
Secondly, the screening technique used can also affect
the DTA. The recommended technique is photography-
based screening which adds the possibility of quality as-
surance [14]. DR screening programs in LMICs are grad-
ually adopting retinal photography. However, in many
clinics without cameras, other methods of retinal exam-
ination that are not necessarily effective as screening
techniques are still used [18]. The sensitivity of direct
ophthalmoscopy in detecting DR is low (65%) and indir-
ect ophthalmoscopy requires extensive training and ex-
perience [21]. Slit lamp bio-microscopy has a high
sensitivity and specificity but also requires significant
training and the availability of a slit lamp. Optical coher-
ence tomography (OCT) for the detection of diabetic
maculopathy is expensive and rarely available outside
tertiary level eye departments in LMICs.
Thirdly, the use of mydriasis can improve the effect-
iveness of task-shifting by increasing the number of
gradable images [18]. However, non-mydriatic imaging
presents several advantages for screening programmes,
like reduced screening time, less inconvenience for pa-
tients and importantly no limitations for using cadres
that may not be allowed to instil eye drops.
Finally, an important consideration in LMICS is the
need to reach rural and remote populations with difficult
access to eye health services. Outreach services delivered
by non-ophthalmologists can be an answer to this prob-
lem, but must ensure that DTA is maintained [18, 20].
Evidence suggests that DTA is higher in hospital-based
screening services compared with outreach services [15].
Several approaches for DR screening in outreach services
that can lend themselves to task-shifting have shown
promising accuracy levels. These include telemedicine
using digital imaging, the use of artificial intelligence-
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supported cameras or smart phone-based technology for
image capture [22–26].
This rapid review aims to identify and synthesise the
peer reviewed literature on the effectiveness of task-
shifting for the detection of DR in LMICs. It is an im-
portant topic given the predicted epidemic of diabetes
mellitus which will disproportionally affect LMICs which
will require major prevention strategies to prevent the
corresponding increase in blindness caused by diabetic
retinopathy. There is a body of evidence to support the
effectiveness of task-shifting in DR screening in high-
income settings which suggests that this may be a viable
strategy in LMICs. However, given the differences in
structure, organization and resourcing in health systems
in LMICs, evidence from HICs may not be generalizable
to these settings. The aim of this rapid review is to sum-
marise the published literature reporting the effective-
ness of task-shifting interventions for the detection of




Can task-shifting improve the detection of diabetic retin-
opathy (DR) compared with eye examination done by
ophthalmologists among adults with diabetes in LMICs?
Protocol and registration
A rapid review was chosen as it is an effective method-
ology to support health programme decision-making
through quality evidence in a timely and cost-effective
manner. These rapid review methods were informed by
the WHO practical guide on rapid reviews and we used
the STARR (Selecting Approaches for Rapid Reviews)
Decision Tool to carefully take into account the possible
limitations introduced by the choice of methodology [27,
28]. We provide the adapted Preferred Reporting Items
for Systematic Reviews and Meta-Analysis Protocols
(PRISMA-P) in Additional file 1. The registration details
are provided in Additional file 2. We will document any
future amendments to the protocol on the Open Science
Framework (OSF) registration site [29] (Table 1).
Eligibility criteria
The review will focus on adults only as they represent the
larger population group at risk of DR and are the target of
population-based screening programmes. We will include
any study that measures any of the uptake and quality out-
comes described in the above table. For included studies,
we will also collect data on cost-effectiveness of the task-
shifting intervention where available.
We will only include peer-reviewed publications
reporting studies conducted in LMICs, as classified by
the World Bank [8] in the last 10 years, in the English
language with available full reports.
The following exclusion criteria will be applied: firstly,
reviews, editorials, case studies, conference abstracts;
secondly, studies involving health education, training
programmes or qualitative studies and thirdly, studies
conducted in high income settings.
Information sources
Following guideline of the STARR Decision tool, we
consulted the review commissioners (FHF) and con-
ducted scoping searches on PubMed to inform the deci-
sion on which information sources to include, balancing
the scope and time available to do the review [30]. The
Cochrane Eyes and Vision Information Specialist (IG)
will develop the search strategy which will include
MEDLINE, Embase, Global Health and the Cochrane
Register of Studies. We will not search the grey literature
as it was considered that the priority for this review is to
summarise the peer-reviewed evidence of effectiveness
of task-shifting interventions required to influence and
change policy and practice.
Search strategy
Search strategy is included in Additional file 3.
Data management and selection process
Two reviewers will independently review each title and
abstract using the online review management software
(Covidence, Veritas Health Innovation, Melbourne,
Australia. Available at www.covidence.org). Any conflicts
will be discussed and resolved. Two reviewers will inde-
pendently screen the full text articles of potentially
Table 1 Eligibility criteria
Population Adults (aged ≥ 18 years) with type 1 or type 2 diabetes in
LMICs
Intervention Task shifting for DR detection: assessment of the target
population for the presence of DR performed by
individuals other than ophthalmologists
Comparison Assessment of the target population for the presence of
DR performed by ophthalmologists
Outcomes Uptake
1. Proportion of patients accessing detection services
among the adult population with type 1 and type 2
diabetes
Quality
2. Proportion of patients diagnosed with DR among those
accessing detection services
3. Severity of DR at detection
4. Diagnostic accuracy of the task-shifting intervention for
DR detection
Cost-effectiveness




Any interventional or observational comparative study
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relevant studies against the inclusion and exclusion cri-
teria and any will discuss any differences to reach con-
sensus. A summary of the study selection process will be
presented in a PRISMA flow diagram.
Risk of bias assessment
One reviewer will use SING critical appraisal checklists
(https://www.sign.ac.uk) to assess the risk of bias for in-
cluded studies. This will be presented in narrative form
with the review findings.
Data extraction
We will develop an Excel data extraction form which
will be tested by two reviewers on three papers. One re-
viewer will conduct data extraction and a second
reviewer will check 10% of the studies for accuracy. If
more than 1% errors are found, another 10% will be
checked (Table 2).
Data synthesis
As we anticipate to find heterogeneity in study design,
interventions, methods and outcome reporting, we will
summarise data narratively following the SWiM report-
ing guidance: Synthesis Without Meta-analysis reporting
items [31]. We will use tables to present the scope and
nature of the evidence and descriptive statistics and vis-
ual displays to present effect estimates. We will use the
GRADE (Grading of Recommendations, Assessment,
Development and Evaluations) approach to assess the
certainty of the evidence for the outcomes of the review
and report any limitations of the synthesis and how they
may affect the conclusions.
Discussion
Differences in health systems organization, structure and
resources will determine the need and success of task-
shifting interventions for DR screening. The review will
examine how these interventions have been used and/or
tested in LMICs. This rapid review will provide context-
specific evidence to inform policy makers and programme
managers tasked with designing and implementing ser-
vices to prevent and manage diabetes and its complica-
tions in low- and middle- income settings.
In balancing the time demands of a rapid review meth-
odology, we have prioritized the peer-reviewed literature
as we considered the more robust evidence for effective-
ness will be found in published scientific journals. We
acknowledge that the limits in searches and time may
potentially miss some evidence which could have been
published before the period included and in the grey
literature.
Supplementary Information
The online version contains supplementary material available at https://doi.
org/10.1186/s13643-020-01553-w.
Additional file 1. Reporting standards – PRISMA-P Checklist.
Additional file 2. Registration OSF: https://osf.io/h5wgr/
Additional file 3. Search strategy.
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Study characteristics
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Country





Training (type and duration)
Scope of the task (screening, treatment, both)
Eye examination procedures (Mydriatic/ non mydriatic,
ophthalmoscopy/photography)
Technology (cameras, ophthalmoscope, slit lamp, OCT)
DR classification (EDTRS, other)
Referral criteria/guidelines (periodicity; immediate referral
for severe cases; compliance tracking)
Quality assurance (audit, retraining, CPD or any other
measure for quality assurance)
Outcomes
1. Proportion of patients accessing detection services
among the adult population with type 1 and type 2
diabetes
2. Proportion of patients diagnosed to have DR among
those accessing detection services
3. Diagnostic accuracy of the task-shifting intervention
for DR detection
4. Severity of DR at detection
5. Cost-effectiveness of the task-shifting intervention
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